Source: Annual Congress 2001 - Treatment of LRTI
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Bugalho, L. Telo, L. Carvalho, F. Froes, C. Nunes, J. P. Mata (Lisbon, Portugal). COPD: antibiotic strategy in infectious exacerbations. Eur Respir J 2001; 16: Suppl. 31, 922

Member's Comments

No comment yet.

Related content which might interest you: The investigation of infectious agents and their antibiotic sensitivities in COPD exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 3s Year: 2006 Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Does influenza vaccination increase consultations for corticosteroid prescriptions or exacerbations of asthma or chronic obstructive pulmonary disease? Source: Annual Congress 2003 - COPD: risk factors and course of disease Year: 2003 Antibiotic choice and repeat prescriptions in infective COPD exacerbations Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Antibiotics in COPD exacerbations: practice and evidence Source: Breathe 2009; 5: 299-301 Year: 2009 Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 Antibiotic treatment and prevention of exacerbations of COPD Source: Eur Respir Monogr 2013; 60: 96-106 Year: 2013 Macrolides in the prevention of COPD exacerbations Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012 Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 COPD exacerbations: impact and prevention Source: Breathe 2013; 9: 434-440 Year: 2013 Viral and bacterial infections in exacerbations of asthma and COPD Source: Annual Congress 2004 - PG9 - The role of infection in airway inflammation and exacerbation Year: 2004 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Prevention of exacerbations of COPD with pharmacotherapy Source: Eur Respir Rev 2009; 19: 119-126 Year: 2010 Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Is CRP a reliable diagnostic tool for infective exacerbations of COPD? Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Prudent use of antibiotics: acute exacerbation of COPD as an example Source: Eur Respir J 2010; 36: 983-985 Year: 2010 An evaluation of exacerbations in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004